BEIJING, 29 April 2016 – The global goal of eradicating polio is one step closer this week, as China along with 154 other countries, make the shift to a new, safer, and more immunogenic polio vaccination schedule – including an unprecedented, globally-synchronized change to ‘switch off’ a now-eradicated strand of polio virus in polio vaccines. This effort will provide better protection for children against polio, particularly those most vulnerable to infection.
BEIJING, 26 April 2016 – China’s national immunization program has averted approximately 5 million deaths of Chinese children in its nearly 40-year history. During this year’s World Immunization Week, held 24-30 April, the World Health Organization (WHO) is urging parents to vaccinate their children – despite recent challenges to the vaccine system in China.
BEIJING, 15 April 2016 – The World Health Organization warmly welcomes proposed changes to China’s vaccines system announced by the State Council, and by the National Health and Family Planning Commission (NHFPC)/ China Food and Drug Administration (CFDA), triggered by the recently-exposed activities of an illegal vaccine re-selling ring operating from Shandong province.
BEIJING, 6 April 2016 – Almost 10% of all adults in China – about 110 million people – currently live with diabetes. Without urgent action to reduce lifestyle risk factors like unhealthy diet and lack of physical activity, that number is expected to increase to 150 million by 2040 – with major health, social and economic consequences.
Highlights from the country
22 March 2016
On 22 March 2016, WHO Regional Director for the Western Pacific Dr Shin Young-soo and National Health and Family Planning Commission (NHFPC) Minister Li launched the new WHO-China Country Cooperation Strategy (CCS). The CCS outlines the priorities for WHO’s work in China over the next 5 years.
14 March 2016
In 2014 WHO recommended offering pre-exposure prophylaxis (PrEP) to men who have sex with men (MSM). On the basis of further evidence of the effectiveness and acceptability of PrEP, WHO has now broadened the recommendation to include all population groups at substantial risk of HIV infection.
Offering PrEP should be a priority for populations with an HIV incidence of about 3 per 100 person-years or higher. PrEP should be an additional prevention choice in a comprehensive package of services that also includes HIV testing, counselling, male and female condoms, lubricants, ARV treatment for partners with HIV infection, voluntary medical male circumcision and harm reduction interventions for people who use drugs.
14 March 2016
WHO Technical Consultation on a comprehensive National Hepatitis Programme in China with a focus on viral hepatitis B and C treatment, Beijing, China, 21 February 2014 : meeting report
China has a heavy burden of viral hepatitis. About 90 million people are chronically infected with the hepatitis B virus and about 7 to 10 million people are estimated to be infected with the hepatitis C virus. The consequence of chronic hepatitis is substantial - liver cancer is the second leading cause of death in China in the agegroup of 35-54 years of age. Effective treatment for hepatitis B and C is available. Studies show that treatment for hepatitis B and C is cost effective, and may reduce death due to chronic hepatitis-related liver disease including liver cancer.
In view of importance of chronic hepatitis in China, a technical consultation was held on 21 February 2014 in Beijing with national stakeholders to discuss the scientific evidence, current challenges and new opportunities for scaling up hepatitis treatment in China using the public health approach.